article thumbnail

Summing up the STAR*D Scandal: The Public was Betrayed, Millions were Harmed, and the Mainstream Media Failed Us All

Mad in America

In 2006, the American Journal of Psychiatry (AJP) published four reports on STAR*D outcomes. Without these imaginary remissions, the reported remission rate in the November 2006 paper would have been around 50%. Nearly 70% of real-world patients could expect to become symptom free with this use of antidepressants.

article thumbnail

Real World Evidence and Cannabis Psychosis

Real Psychiatry

In this case they selected a cohort of 1772 patient with a diagnosis of cannabis induced psychosis (CIP) from Swedish registry and insurance data between January 2006 and December 2021. Exclusion criteria included any previous diagnosis of substance induced psychosis, schizophrenia, or bipolar disorder.

Legal 89
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why Failed Psychiatry Lives On: Its Industrial Complex, Politics, & Technology Worship

Mad in America

One of many psychiatrists exposed by 2008 Congressional hearings on psychiatry’s financial relationship with drug companies was Harvard psychiatrist Joseph Biederman—credited with creating pediatric bipolar disorder—who received $1.6 million in consulting fees from drug makers from 2000 to 2007.

article thumbnail

Are Psychiatrists More Mad Than Their Patients?

Mad in America

In 2006, a report from the Danish Board of Health showed that half of the patients were in treatment with more than one psychosis pill simultaneously, 29 although both national and international guidelines recommend against it. Depressive and bipolar disorders: patients attitudes and beliefs towards depression and antidepressants.

article thumbnail

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Mad in America

This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray).

article thumbnail

For-Profit Healthcare Is a Predator; Its Main Prey Is Our Young

Mad in America

But now they often say Since they have bipolar disorder, theyll never be able to manage their emotions or achieve any stability. Phillips, C Medicine Goes to School: Teachers as Sickness Brokers for ADHD PLoS Med, 2006 Apr 11;3(4)e182. Its debilitating symptoms will make their lives a constant battle. Jewett, C F.D.A.s

article thumbnail

Medication Overload, Part II: The Explosion of Drugs for Kids

Mad in America

Rebecca started seeing a psychiatrist at the age of two and was diagnosed with attention-deficit hyperactivity disorder and pediatric bipolar disorder. After suffering horrible abuse, Rebecca died in 2006 from an overdose of psychiatric drugs. She was four years old. The civil case was settled in January of 2011 for $2.5